MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Proof-of-concept study testing bevantolol (SOM3355) as treatment of chorea in Huntington’s disease

    J. Gamez, M. Calopa, E. Muñoz, A. Ferré, O. Huertas, K. Mcallister, N. Reig, C. Scart-Grès, R. Insa, J. Kulisevsky (Barcelona, Spain)

    Objective: Proof-of-concept phase IIa study assessing bevantolol (SOM3355) efficacy and safety in reducing chorea in Huntington’s disease (HD). Background: Bevantolol hydrochloride, a β1‐adrenoceptor antagonist used…
  • MDS Virtual Congress 2021

    The Huntington’s Disease Structured Interview of Function (HD-SIF): A remotely administered caregiver interview for later stage HD

    M. Roche, R. Fuller, L. Cherneski, O. Handley, S. Capodarca, E. Neacy, S. Frank, G. Stebbins, S. Sathe, C. Sampaio (Princeton, USA)

    Objective: To create structured interviews for the UHDRS ’99 functional scales that can be remotely administered to caregivers of Huntington’s disease gene expansion carriers (HDGECs)…
  • MDS Virtual Congress 2021

    Lance-Adams Syndrome: A case series in El Salvador

    J. Lopez-Castellanos, J. Lopez-Contreras (Little Rock, USA)

    Objective: To describe the clinical presentation and response to treatment of cases of Lance-Adams Syndrome in a Movement Disorders Clinic in El Salvador. Background: Lance-Adams…
  • MDS Virtual Congress 2021

    Visualising tau in patients with progressive supranuclear palsy using PI2620-PET

    L. Vivash, HM. Tang, K. Bertram, TJ. O'Brien (Melbourne, Australia)

    Objective: This study investigates the use of a new tau-specific PET radiotracer, [18F]-PI-2620, as a tool for visualising tau in the living brain. Background: The…
  • MDS Virtual Congress 2021

    Pallidal recordings in fully implanted dystonic patients: preliminary results

    C. Palmisano, P. Capetian, Y. Thenaisie, A. Canessa, E. Moraud, M. Contarino, I. Isaias (Würzburg, Germany)

    Objective: To describe oscillatory patterns of pallidal local field potentials (LFP) in fully implanted patients with dystonia. ​​​ Background: New implantable devices for deep brain stimulation…
  • MDS Virtual Congress 2021

    How can patients’ trajectories inform the co-design of an integrated care network for people living with Parkinson’s Disease?

    S. Grosjean, J. Farré Coma, O. Gal, A. Laffan, A. Sendra, J. Stuempel, T. Mestre (Ottawa, Canada)

    Objective: The aim of this study is to provide a better understanding of how patients’ experience could inform the design of an integrated care network…
  • MDS Virtual Congress 2021

    Alpha-synuclein oligomers detection by proximity ligation assay in skin biopsy is a biomarker for Parkinson’s disease

    E. Vacchi, C. Senese, S. Pinton, A. Kaelin-Lang, G. Melli (Lugano, Switzerland)

    Objective: To assess the presence of oligomeric alpha-synuclein (αSyn), an early pathogenic species, in skin nerve fibers of patients with Parkinson’s disease (PD) and atypical…
  • MDS Virtual Congress 2021

    The alien hand syndrome

    A. Balan, I. Buraga (Bucharest, Romania)

    Objective: This case is presented to create awareness of this interesting clinical scenario, which can be terrifying to the patients and confusing to the physicians…
  • MDS Virtual Congress 2021

    Feasibility of Instituting Graduated High intensity Training (FIGHT-PD); Protocol for a non-contact boxing exercise study

    D. Blacker, R. Fazio, C. Tucak, M. Turner, S. Rajandran, T. Cruickshank (Nedlands, Australia)

    Objective: 1. To determine the feasibility and logistics of conducting a non-contact boxing exercise program for PD patients. 2. To determine the tolerability of the…
  • MDS Virtual Congress 2021

    Long-Term Safety and Efficacy of Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease

    S. Factor, W. Ondo, S. Isaacson, I. Zhang, E. Pappert, B. Navia (Atlanta, USA)

    Objective: Evaluate long-term safety (LTS), tolerability, and efficacy of apomorphine sublingual film (APL) for on-demand treatment of “OFF” episodes in patients with Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley